Vibrant America Clinical Laboratory
Private Company
Total funding raised: $35M
Overview
Vibrant America is a commercial-stage clinical laboratory specializing in high-volume, automated diagnostic testing. It has positioned itself as a cost-effective provider with a rapidly expanding test menu, notably gaining FDA Emergency Use Authorization for COVID-19 serum and dried blood spot tests and achieving New York State accreditation. The company's strategy centers on technological innovation in multiplex testing and automation to drive down costs and improve turnaround times, aiming to become a leader in the autoimmune diagnostics segment while serving a national client base.
Technology Platform
High-throughput automated laboratory utilizing multiplex immunoassay technology to test multiple analytes from a single sample, with capabilities for both standard serum and dried blood spot (DBS) testing. Supported by a proprietary web-based ordering and reporting portal.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Vibrant America competes directly with giant national reference laboratories (LabCorp, Quest Diagnostics) and numerous regional and specialty labs. Its strategy is to differentiate on cost, turnaround time, and focused excellence in multiplexed testing, particularly in autoimmune diagnostics, where it faces competition from specialized players like Exagen and Eurofins.